T1	Nutrient 29 53	Galacto-oligosaccharides
T2	INCREASES 54 63	Increases
T3	Microorganism 64 78	Bifidobacteria
T4	INCREASES 84 87	Not
T5	Physiology 88 107	Insulin Sensitivity
T6	Population 112 141	ObeseÂ Prediabetic Individuals
T7	Disease 112 117	Obese
T8	Physiology 195 200;213 223	lipid metabolism
T9	Physiology 205 223	glucose metabolism
T10	Physiology 225 232	satiety
T11	Physiology 238 268	chronic low-grade inflammation
T12	Disease 286 293	obesity
T13	Disease 298 313	type 2 diabetes
T14	PREDISPOSES 272 282	contribute
T15	Metabolite 360 382	short-chain fatty acid
T16	Metabolite 384 388	SCFA
T17	Metabolite 390 397	acetate
T18	Nutrient 509 533	galacto-oligosaccharides
T19	Nutrient 535 538	GOS
T21	Nutrient 544 560	acetogenic fiber
T22	Methodology 655 718	double-blinded, placebo-controlled, parallel intervention study
T23	Disease 725 735	overweight
T24	Disease 739 744	obese
T25	Measurement 746 761	body mass index
T26	Population 725 817	overweight or obese (body mass index, 28-40 kg/m2) prediabetic men and women (ages, 45-70 y)
T27	Disease 776 787	prediabetic
T28	Physiology 1277 1299	inflammatory responses
T29	Nutrient 957 960	GOS
T30	Nutrient 984 996	maltodextrin
T31	Physiology 1094 1104;1117 1143	peripheral tissue insulin sensitivity
T32	Physiology 1109 1143	adipose tissue insulin sensitivity
T33	Metabolite 1175 1181;1192 1196	plasma SCFA
T34	Metabolite 1186 1196	fecal SCFA
T35	Physiology 1198 1216	energy expenditure
T36	Physiology 1221 1240	substrate oxidation
T37	Measurement 1242 1258	body composition
T38	Physiology 1264 1272;1290 1299	hormonal responses
T39	Nutrient 1339 1342	GOS
T40	Physiology 1346 1376	peripheral insulin sensitivity
T41	Methodology 1394 1434	hyperinsulinemic-euglycemic clamp method
T42	AFFECTS 1329 1335	effect
T43	Nutrient 1475 1478	GOS
T44	INCREASES 1497 1506	increased
T45	Microorganism 1524 1539	Bifidobacterium
T46	Biospecimen 1551 1556	feces
T47	Biospecimen 1625 1638	fecal samples
T48	Metabolite 1696 1701;1720 1724	fecal SCFA
T49	Metabolite 1705 1724	fasting plasma SCFA
T50	Physiology 1773 1793	gut-derived hormones
T51	Chemical 1795 1804	incretins
T52	Chemical 1806 1840	lipopolysaccharide-binding protein
T53	Measurement 1851 1874	markers of inflammation
T54	AFFECTS 1661 1692	did not observe any differences
T55	AFFECTS 1889 1915	no significant alterations
T56	Physiology 1919 1929;1942 1968	peripheral tissue insulin sensitivity
T57	Physiology 1934 1968	adipose tissue insulin sensitivity
T58	Measurement 1970 1986	body composition
T59	Physiology 1992 1998;2013 2023	energy metabolism
T60	Physiology 2003 2023	substrate metabolism
T61	Nutrient 2080 2083	GOS
T62	INCREASES 2096 2105	increased
T63	Microorganism 2112 2127	Bifidobacterium
T64	AFFECTS 2156 2191	did not produce significant changes
T65	Physiology 2195 2214	insulin sensitivity
T66	Physiology 2240 2257	energy metabolism
T67	Population 2261 2306	overweight or obese prediabetic men and women
T68	Disease 2261 2271	overweight
T69	Disease 2275 2280	obese
T70	Disease 2281 2292	prediabetic
T71	Disease 118 129	Prediabetic
T72	DiversityMetric 1600 1608	richness
T73	AFFECTS 1644 1656	not affected
T74	Physiology 2226 2235;2247 2257	substrate metabolism
T75	DiversityMetric 1612 1621	diversity
E1	INCREASES:T2 Agent:T1 Theme:T3
E2	INCREASES:T4 Agent:T1 Theme:T5
E3	PREDISPOSES:T14 Agent:T11 Theme:T12
E4	PREDISPOSES:T14 Agent:T10 Theme:T12
E5	PREDISPOSES:T14 Agent:T9 Theme:T12
E6	PREDISPOSES:T14 Agent:T8 Theme:T12
E7	PREDISPOSES:T14 Agent:T8 Theme:T13
E8	PREDISPOSES:T14 Agent:T9 Theme:T13
E9	PREDISPOSES:T14 Agent:T11 Theme:T13
E10	PREDISPOSES:T14 Agent:T10 Theme:T13
E11	AFFECTS:T42 Agent:T39 Theme:T40
E12	INCREASES:T44 Agent:T43 Theme:T45
E13	AFFECTS:T54 Agent:T43 Theme:T48
E14	AFFECTS:T54 Agent:T43 Theme:T49
E15	AFFECTS:T54 Agent:T43 Theme:T50
E16	AFFECTS:T54 Agent:T43 Theme:T51
E17	AFFECTS:T54 Agent:T43 Theme:T52
E18	AFFECTS:T54 Agent:T43 Theme:T53
E19	AFFECTS:T55 Agent:T43 Theme:T56
E20	AFFECTS:T55 Agent:T43 Theme:T57
E21	AFFECTS:T55 Agent:T43 Theme:T58
E22	AFFECTS:T55 Agent:T43 Theme:T59
E23	AFFECTS:T55 Agent:T43 Theme:T60
E24	INCREASES:T62 Agent:T61 Theme:T63
E25	AFFECTS:T64 Agent:T61 Theme:T65
E26	AFFECTS:T64 Agent:T61 Theme:T66
E27	AFFECTS:T73 Theme:T72 Agent:T43
E28	AFFECTS:T73 Theme:T75 Agent:T43
A1	Factuality E2 Negated
A2	Factuality E13 Negated
A3	Factuality E14 Negated
A4	Factuality E15 Negated
A5	Factuality E16 Negated
A6	Factuality E17 Negated
A7	Factuality E18 Negated
A8	Factuality E19 Negated
A9	Factuality E20 Negated
A10	Factuality E21 Negated
A11	Factuality E22 Negated
A12	Factuality E23 Negated
A13	Factuality E25 Negated
A14	Factuality E26 Negated
A15	Factuality E27 Negated
A16	Factuality E28 Negated
N1	Reference T1 CHEBI:24151	galactooligosaccharide
N2	Reference T3 NCBITAXON:1678	Bifidobacterium
N3	Reference T5 OCHV:C0920563	insulin sensitivity
N4	Reference T7 NCIT:C3283	Obesity
N5	Reference T8 NCIT:C19405	Lipid Metabolic Process
N6	Reference T9 OCHV:41587	glucose metabolism
N7	Reference T10 MESH:D012527	Satiation
N8	Reference T11 NCIT:C174450	Chronic Inflammation
N9	Reference T12 NCIT:C3283	Obesity
N10	Reference T13 NCIT:C26747	Type 2 Diabetes Mellitus
N11	Reference T15 CHEBI:26666	short-chain fatty acid
N12	Reference T16 CHEBI:26666	short-chain fatty acid
N13	Reference T17 CHEBI:30089	acetate
N14	Reference T18 CHEBI:24151	galactooligosaccharide
N15	Reference T19 CHEBI:24151	galactooligosaccharide
N16	Reference T23 NCIT:C94250	Overweight
N17	Reference T24 NCIT:C3283	Obesity
N18	Reference T25 NCIT:C16358	Body Mass Index
N19	Reference T27 NCIT:C122685	Prediabetes
N20	Reference T28 NCIT:C20151	Inflammatory Response
N21	Reference T29 CHEBI:24151	galactooligosaccharide
N22	Reference T30 CHEBI:25140	maltodextrin
N23	Reference T31 MESH:D007333	Insulin Resistance
N24	Reference T33 CHEBI:26666	short-chain fatty acid
N25	Reference T34 CHEBI:26666	short-chain fatty acid
N26	Reference T35 NCIT:C147491	Energy Expenditure
N27	Reference T37 MESH:D001823	Body Composition
N28	Reference T39 CHEBI:24151	galactooligosaccharide
N29	Reference T40 MESH:D007333	Insulin Resistance
N30	Reference T43 CHEBI:24151	galactooligosaccharide
N31	Reference T45 NCBITAXON:1678	Bifidobacterium
N32	Reference T48 CHEBI:26666	short-chain fatty acid
N33	Reference T49 CHEBI:26666	short-chain fatty acid
N34	Reference T50 OCHV:C0684155	gut hormone
N35	Reference T51 MESH:D054795	Incretins
N36	Reference T52 NCIT:C105867	Lipopolysaccharide-Binding Protein
N37	Reference T56 MESH:D007333	Insulin Resistance
N38	Reference T58 MESH:D001823	Body Composition
N39	Reference T59 NCIT:C16547	Energy Metabolism Process
N40	Reference T61 CHEBI:24151	galactooligosaccharide
N41	Reference T63 NCBITAXON:1678	Bifidobacterium
N42	Reference T65 OCHV:C0920563	insulin sensitivity
N43	Reference T66 NCIT:C16547	Energy Metabolism Process
N44	Reference T68 NCIT:C94250	Overweight
N45	Reference T69 NCIT:C3283	Obesity
N46	Reference T70 NCIT:C122685	Prediabetes
N47	Reference T71 NCIT:C122685	Prediabetes
